Secondary mitral regurgitation in heart failure with reduced or preserved left ventricular ejection fraction

Cardiology (Switzerland)

Volumn 125, Issue 2, 2013, Pages 110-117

  Ennezat, Pierre Vladimir ^a   Maréchaux, Sylvestre ^b   Pibarot, Philippe ^c   Le Jemtel, Thierry H ^d  

^a Groupe Hospitalier Mutualiste de Grenoble   (France)

^b UNIV LILLE   (France)

^c LAVAL UNIVERSITY   (Canada)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diastolic dysfunction; Echocardiography; Heart failure; Secondary mitral regurgitation

Indexed keywords

ACUTE HEART FAILURE; CARDIAC PATIENT; CLINICAL FEATURE; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; BETA ADRENERGIC RECEPTOR BLOCKING; COLOR ULTRASOUND FLOWMETRY; CONGESTIVE CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; HEART FAILURE; HEART PAPILLARY MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE PERFORMANCE; KIDNEY FUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; ORGAN PERFUSION; PROGNOSIS; SYSTOLIC BLOOD PRESSURE;

AGED; ECHOCARDIOGRAPHY, DOPPLER; HEART FAILURE; HUMANS; MITRAL VALVE INSUFFICIENCY; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84878059091     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000350356     Document Type: Review

References (61)

1. Maréchaux S, Pibarot P, Ennezat PV: Insights into functional mitral regurgitation despite preserved LVEF. Arch Cardiovasc Dis 2011; 104: 131-133.
2. Maréchaux S, Neicu DV, Braun S, et al: Functional mitral regurgitation: A link to pulmonary hypertension in heart failure with preserved ejection fraction. J Card Fail 2011; 17: 806-812.
3. Rossi A, Dini FL, Faggiano P, et al: Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1,256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 2011; 97: 1675-1680.
4. Bursi F, Enriquez-Sarano M, Nkomo VT, et al: Heart failure and death after myocardial infarction in the community: The emerging role of mitral regurgitation. Circulation 2005; 111: 295-301. (Pubitemid 40165335)
5. Color version available online 5 Hung J, Papakostas L, Tahta SA, et al: Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: Continued LV remodeling as a moving target. Circulation 2004; 110: 1185-1190.
6. Grande-Allen KJ, Borowski AG, Troughton RW, et al: Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: An extracellular matrix and echocardiographic study. J Am Coll Cardiol 2005; 45: 54-61. (Pubitemid 40052025)
7. Chaput M, Handschumacher MD, Guerrero JL, Holmvang G, Dal-Bianco JP, Sullivan S, Vlahakes GJ, Hung J, Levine RA, Leducq Foundation MITRAL Transatlantic Network: Mitral leaflet adaptation to ventricular remodeling: Prospective changes in a model of ischemic mitral regurgitation. Circulation 2009; 120:S99-S103.
8. Agricola E, Oppizzi M, Maisano F, et al: Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr 2004; 5: 326-334. (Pubitemid 39198917)
9. Magne J, Senechal M, Dumesnil JG, et al: Ischemic mitral regurgitation: A complex multifaceted disease. Cardiology 2009; 112: 244-259.
10. Lancellotti P, Moura L, Pierard LA, et al: European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2. Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: 307-332.
11. Park S-M, Park SW, Casaclang-Verzosa G, et al: Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: Data from the Acorn trial. Am Heart J 2009; 157: 762.e3-e10.
12. Van de Veire NR, De Sutter J: Effect of ischemic mitral regurgitation on the ratio of early transmitral flow velocity to mitral annulus early diastolic velocity in patients with stable coronary artery disease. Am J Cardiol 2006; 97: 1449-1451.
13. Maréchaux S, Pinçon C, Poueymidanette M, et al: Elevated left atrial pressure estimated by Doppler echocardiography is a key determinant of mitral valve tenting in functional mitral regurgitation. Heart 2010; 96: 289-297.
14. Enriquez-Sarano M, Rossi A, Seward JB, et al: Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 1997; 29: 153-159. (Pubitemid 27028733)
15. Miller WL, Mahoney DW, Michelena HI, et al: Contribution of ventricular diastolic dysfunction to pulmonary hypertension complicating chronic systolic heart failure. JACC Cardiovasc Imaging 2011; 4: 946-954.
16. Keren G, Bier A, Strom JA, Laniado S, Sonnenblick EH, Le Jemtel TH: Dynamics of mitral regurgitation during nitroglycerin therapy: A Doppler echocardiographic study. Am Heart J 1986; 112: 517-525. (Pubitemid 16046461)
17. Seneviratne B, Moore GA, West PD: Effect of captopril on functional mitral regurgitation in dilated heart failure: A randomised double blind placebo controlled trial. Br Heart J 1994; 72: 63-68. (Pubitemid 24245387)
18. Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM: Effe cts of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chro nic heart failure. Am J Cardiol 1999; 83: 1201-1205. (Pubitemid 29183917)
19. Yared K, Lam KM, Hung J: The use of exercise echocardiography in the evaluation of mitral regurgitation. Curr Cardiol Rev 2009; 5: 312-322.
20. Lancellotti P, Lebrun F, Pierard LA: Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2003; 42: 1921-1928. (Pubitemid 37485566)
21. Ennezat PV, Maréchaux S, Le Tourneau T, et al: Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J 2006; 27: 679-683.
22. Ennezat PV, Gal B, Kouakam C, et al: Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: An acute echocardiographic study. Heart 2006; 92: 1091-1095. (Pubitemid 44125224)
23. Maréchaux S, Pincon C, Gal B, et al: Functional mitral regurgitation at rest determines the acute hemodynamic response to cardiac resynchronization therapy during exercise: An acute exercise echocardiographic study. J Am Soc Echocardiogr 2009; 22: 464-471.
24. Breithardt O, Sinha A, Schwammenthal E, et al: Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am College Cardiol 2003; 41: 765-770. (Pubitemid 36308383)
25. Lancellotti P, Gérard PL, Piérard LA: Longterm outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005; 26: 1528-1532. (Pubitemid 41373494)
26. Ennezat PV, Maréchaux S, Huerre C, et al: Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest. Am Heart J 2008; 155: 752-757.
27. Piérard LA, Lancellotti P: The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 2004; 351: 1627-1634. (Pubitemid 39350423)
28. Klapholz M, Maurer M, Lowe A, et al: Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York Heart Failure Registry. J Am Coll Cardiol 2004; 43: 1432-1438. (Pubitemid 38496351)
29. Henkel DM, Redfield MM, Weston SA, et al: Death in heart failure: A community perspective. Circ Heart Fail 2008; 1: 91-97.
30. Massie BM, Carson PE, McMurray JJ, et al: Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359: 2456-2467.
31. Yusuf S, Pfeffer MA, Swedberg K, et al: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003; 362: 777-781. (Pubitemid 37093918)
32. Borlaug BA, Paulus WJ: Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment. Eur Heart J 2011; 32: 670-679.
33. Ennezat PV, Maréchaux S, Six-Carpentier M, et al: Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction. Nephrol Dial Transplant 2011; 26: 3908-3913.
34. Maréchaux S, Six-Carpentier MM, Bouabdallaoui N, et al: Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction. Heart Vessels 2011; 26: 313-320.
35. Rusinaru D, Buiciuc O, Houpe D, et al: Renal function and long-term survival after hospital discharge in heart failure with preserved ejection fraction. Int J Cardiol 2011; 147: 278-282.
36. Tribouilloy C, Rusinaru D, Mahjoub H, et al: Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: A prospective five-year study. Heart 2008; 94: 1450-1455.
37. Tribouilloy C, Rusinaru D, Mahjoub H, et al: Prognosis of heart failure with preserved ejection fraction: A 5 year prospective populationbased study. Eur Heart J 2008; 29: 339-347. (Pubitemid 351197754)
38. Butany J, Ahluwalia MS, Nair V, et al: Age-related morphological changes in cardiac valves. Geriatr Aging 2003; 6: 49-54. (Pubitemid 37336712)
39. Barasch E, Gottdiener JS, Larsen EK, et al: Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS). Am Heart J 2006; 151: 39-47. (Pubitemid 41815328)
40. Ennezat PV, Bellouin A, Maréchaux S, Juthier F, Fayad G, Vincentelli A, Berrébi A, Auffray JL, Bauchart JJ, Mouquet F, Montaigne D, Asseman P, Le Jemtel TH, Pibarot P: Pivotal role of bedside Doppler echocardiography in the assessment of patients with acute heart failure and mitral regurgitation. Cardiology 2009; 113: 249-259.
41. Ennezat PV, Logeart D, Berrebi A, Vincentelli A, Maréchaux S: Key role of Doppler echocardiography in the emergency management of elderly patients. Arch Cardiovasc Dis 2010; 103: 115-128.
42. Melenovsky V, Borlaug BA, Rosen B, et al: Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: The role of atrial remodeling/dysfunction. J Am Coll Cardiol 2007; 49: 198-207. (Pubitemid 46070209)
43. Tanimoto M, Pai RG: Effect of isolated left atrial enlargement on mitral annular size and valve competence. Am J Cardiol 1996; 77: 769-774. (Pubitemid 26116698)
44. Gertz ZM, Raina A, Saghy L, et al: Evidence of atrial functional mitral regurgitation due to atrial fibrillation: Reversal with arrhythmia control. J Am Coll Cardiol 2011; 58: 1474-1481.
45. Yu CM, Zhang Q, Yip GW, Lee PW, Kum LC, Lam YY, Fung JW: Diastolic and systolic asynchrony in patients with diastolic heart failure: A common but ignored condition. J Am Coll Cardiol 2007; 49: 97-105. (Pubitemid 46039794)
46. Chang SA, Kim HK, Kim DH, et al: Left ventricular systolic and diastolic dyssynchrony in asymptomatic hypertensive patients. J Am Soc Echocardiogr 2009; 22: 337-342.
47. Park HE, Chang SA, Kim HK, et al: Impact of loading condition on the 2D speckle trackingderived left ventricular dyssynchrony index in nonischemic dilated cardiomyopathy. Circ Cardiovasc Imaging 2010; 3: 272-281.
48. Hung J, Otsuji Y, Handschumacher MD, et al: Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: Physiologic insights from the proximal flow convergence technique. J Am Coll Cardiol 1999; 33: 538-545. (Pubitemid 29234218)
49. Agricola E, D'Amato R, Stella S, et al: Effects of mild ischemic mitral regurgitation on ventricular remodeling and its contribution to congestive heart failure. J Am Soc Echocardiogr 2011; 24: 1376-1382.
50. Holtz JE, Upadhyaya DS, Cohen BE, et al: Mitral annular calcium, inducible myocardial ischemia, and cardiovascular events in outpatients with coronary heart disease (from the Heart and Soul Study). Am J Cardiol 2012; 109: 1092-1096.
51. Lam CS, Roger VL, Rodeheffer RJ, et al: Pulmonary hypertension in heart failure with preserved ejection fraction: A community-based study. J Am Coll Cardiol 2009; 53: 1119-1126.
52. Maréchaux S, Terrade J, Biausque F, et al: Exercise-induced functional mitral regurgitation in heart failure and preserved ejection fraction: A new entity. Eur J Echocardiogr 2010; 11:E14.
53. Ennezat PV, Lefetz Y, Maréchaux S, et al: Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail 2008; 14: 475-480.
54. Pecini R, Hammer-Hansen S, Dalsgaard M, et al: Determinants of exercise-induced increase of mitral regurgitation in patients with acute coronary syndromes. Echocardiography 2010; 27: 567-574.
55. Bouzas-Mosquera A, Peteiro J: Mitral regurgitation during exercise in patients with left ventricular systolic dysfunction. Am Heart J 2008; 156:e27.
56. Ha JW, Oh JK, Pellikka PA, et al: Diastolic stress echocardiography: A novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise Doppler echocardiography. J Am Soc Echocardiogr 2005; 18: 63-68. (Pubitemid 40051198)
57. Tan YT, Wenzelburger F, Lee E, et al: The pathophysiology of heart failure with normal ejection fraction: Exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 2009; 54: 36-46.
58. Borlaug BA, Olson TP, Lam CS, et al: Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010; 56: 845-854.
59. Maeder MT, Thompson BR, Brunner-La Rocca HP, et al: Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 2010; 56: 855-863.
60. Donal E, Thebault C, Lund LH, et al: Heart failure with a preserved ejection fraction additive value of an exercise stress echocardiography. Eur Heart J Cardiovasc Imaging 2012; 13: 656-665.
61. Donal E, Lund LH, Linde C, et al: Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction. Eur J Heart Fail 2009; 11: 198-204.